1/43
Comprehensive vocabulary flashcards covering Evidence-Based Practice (EBP), study designs, quality appraisal, epidemiology, biostatistics, public health surveillance, and communicable disease management from NS340 Week 3 lecture notes.

Evidence-Based Practice (EBP)
The integration of the best available research, clinical expertise, and patient or community preferences to guide healthcare decisions.
Barriers to EBP
Barrier | What to look for in a question |
|---|---|
Lack of Knowledge | Nurse doesn't know how |
Resistance to Change | Nurse doesn't want to change |
Implementation Gap | Nurse knows the evidence but doesn't apply it |
Limited Resources | Nurse doesn't have the tools or access |
Lack of Organizational Support | Leadership doesn't provide support |
PICOT
Letter | Meaning | What you're asking |
|---|---|---|
P | Population/Patient/Problem | Who is the patient or population? |
I | Intervention | What treatment or action are you considering? |
C | Comparison | What are you comparing the intervention to? |
O | Outcome | What result do you want? |
T | Time | Over what period? |
Seven Steps of EBP
Step | Meaning | Simple explanation |
|---|---|---|
0. Cultivate a Spirit of Inquiry | Be curious | Question why things are done a certain way. |
1. Ask a PICOT Question | Identify the problem | Develop a focused clinical question. |
2. Search for Evidence | Find research | Use databases like PubMed or CINAHL. |
3. Critically Appraise Evidence | Evaluate research | Determine whether the evidence is reliable, valid, and relevant. |
4. Integrate Evidence | Apply findings | Combine research with clinical expertise and patient preferences to make a practice decision. |
5. Evaluate Outcomes | Check results | Determine whether the change improved patient care. |
6. Disseminate Outcomes | Share findings | Communicate results with other healthcare professionals. |

Hierarchy of Evidence
A ranked pyramid of study designs arranged from strongest to weakest: Level I (Systematic Reviews & Meta-Analyses), Level II (Randomized Controlled Trials), Level III (Controlled Trials without Randomization), Level IV (Case-Control & Cohort Studies), Level V (Systematic Reviews of Qualitative Studies), Level VI (Single Descriptive / Qualitative Studies), and Level VII (Expert Opinion).
Observational Study
A category of study designs where investigators examine relationships or patterns in data by observing subjects without manipulating or assigning exposures.
Experimental Study
A study design where investigators directly control the intervention by assigning exposures and comparing outcomes, serving as the strongest design for causal inference.
Cross-Sectional Study
An observational study design capturing a "snapshot" of exposures and outcomes at a single point in time; best for determining disease prevalence, estimating public health burden, planning, and hypothesis generation, with the limitation that it cannot establish causality.
Case-Control Study
An observational study design that compares subjects with a specific outcome or disease to subjects without the outcome to retrospectively assess prior exposures; best for rare diseases and outbreak investigations, but limited by recall bias and an inability to measure incidence.
Cohort Study
An observational study design that tracks an exposed and unexposed group forward over time to identify who develops the outcome; best for studying common exposures, multiple outcomes, long-term risk assessment, and natural history, but is costly and time-consuming.
Randomized Controlled Trial (RCT)
The gold-standard prospective experimental study design using random assignment to test interventions for causal effect against a comparison group; limited by high financial cost and ethical constraints.
Quasi-Experimental Study
An experimental study design where an intervention is tested without full random assignment, commonly utilized in pragmatic and real-world clinical settings.
AHRQ Appraisal Triad
An evidence appraisal model developed by the Agency for Healthcare Research and Quality evaluating three components: Quality (strength of evidence, study bias, and methodology), Quantity (number of studies, sample sizes, and effect sizes), and Consistency (similarity of findings across studies, alignment of syntheses, and stability over time).
Quality Assurance (QA)
A reactive, backward-looking monitoring processâoften led by governmental agenciesâdesigned to watch and evaluate services to confirm established standards are adhered to and correct identified deficiencies.
Quality Improvement (QI)
A proactive, forward-looking process that continuously refines clinical systems, reduces variation in healthcare delivery, enhances patient outcomes, and supports accreditation standards using structured frameworks such as PDSA.

PDSA Cycle
A continuous quality improvement model consisting of Plan (define change, state question, predict outcome, plan test), Do (carry out small-scale test and document observations), Study (analyze results, compare actual against predicted outcomes, identify learning), and Act (adopt, adapt, or abandon the change to make it sustainable or begin another cycle).
Major Accrediting Bodies
External organizations setting operational quality standards: The Joint Commission (hospitals, health systems, behavioral health, home care), PHAB (Public Health Accreditation Board for health departments), CCNE and ACEN (nursing education programs), and CARF, NCQA, and URAC (specialty bodies for rehabilitation, managed care, and healthcare operations).
Community-Based Participatory Research (CBPR)
A collaborative approach where community members are full partners rather than research subjects across all stages (problem identification, study design, data collection, analysis, intervention development, and dissemination), guided by leveraging community strengths, developing local leadership, and generating sustainable interventions.
Wilder's Community-Engagement Research Model
A framework delineating levels of community involvement and associated participant roles: Informed corresponds to Advisor; Involved corresponds to Collaborator; Directed corresponds to Leader.
Epidemiology
The study of how diseases and health-related events occur and spread within populations, and the factors that influence them, centered on investigating Person (who is affected), Place (where it occurs), and Time (when it occurs).
Six Core Functions of Epidemiology
The interconnected operational cycle of epidemiology: Surveillance (continuous monitoring and threat detection), Investigation (inquiry into unusual trends), Analytic Studies (testing exposure-outcome relationships to establish cause), Evaluation (assessing intervention efficacy), Linkages (multidisciplinary partnerships), and Policy Development (translating epidemiological data into health regulations and laws).
Reliability
The precision, consistency, or repeatability of a clinical or epidemiological measurement instrument.
Validity
The degree to which a measurement instrument accurately reflects what it is intended to evaluate, measured specifically through sensitivity and specificity.

Sensitivity
The true positive rate of a diagnostic tool, representing its ability to correctly identify persons who have the disease; high sensitivity minimizes false negatives.
Specificity
The true negative rate of a diagnostic tool, representing its ability to correctly identify persons who do not have the disease; high specificity minimizes false positives.
Point Prevalence
The proportion of individuals in a population exhibiting a disease at a single specific point in time.
Period Prevalence
The proportion of individuals in a population exhibiting a disease throughout a designated time interval.
Incidence Rate
The rate at which new cases of disease arise in a population at risk over a specified time period: Incidence Rate=Number of persons at risk during that time periodNumber of new cases occurring during a specified periodâĂ100,000.
Crude Mortality Rate
The total proportion of deaths occurring from any cause within a general population over a calendar year: Crude Mortality Rate=Midyear populationNumber of deaths occurring in 1 yearâĂ100,000.
Cause-Specific Mortality Rate
The mortality rate in a general population resulting from a specific disease within a year: Cause-Specific Mortality Rate=Midyear populationTotal deaths from a stated cause in 1 yearâĂ100,000.
Case Fatality Rate
The proportion of diagnosed cases of a specific disease that end in death, indicating the disease's lethality: Case Fatality Rate=Number of cases of the same diseaseNumber of deaths from a specific diseaseâĂ100.
Proportionate Mortality
The proportion of all deaths in a given population and time period attributable to a single specific cause: Proportionate Mortality=Total deaths in the same time periodNumber of deaths from a specific cause within a time periodâĂ100.
Epidemiological Triangle
A model of disease causation requiring an interaction among three components for illness to develop: Agent (virus, bacteria, or fungus), Host (human or animal), and Environment (factors sustaining the agent and host).
Active Immunity
Immunity produced directly by an individual's immune system creating antibodies; acquired either naturally (following recovery from an infection) or artificially (induced via a vaccine).
Passive Immunity
Temporary immunity gained by transferring preformed antibodies from an outside source rather than producing them internally; acquired naturally (maternal-fetal transfer through placenta or breast milk) or artificially (administration of immune globulin/serum).
Endemic vs. Epidemic vs. Pandemic
Patterns of disease frequency: Endemic describes constant baseline presence in a specific group; Epidemic describes an occurrence clearly exceeding normal expectancy in a given community; Pandemic describes an epidemic that has spread across national and continental boundaries.
Natural History of Disease
A timeline depicting the standard clinical progression of a pathological condition from exposure to resolution in the absence of treatment or medical intervention.
Agents of Bioterrorism
Microorganisms or toxins intentionally disseminated to cause disease or death: Anthrax (spores in livestock treated with ciprofloxacin), Plague (flea vector), Botulism (toxin causing paralysis; treated with antitoxin; linked to honey in infants under 1 and canned foods), Smallpox (viral agent eradicated in 1979), Viral Hemorrhagic Fevers (Ebola, Marburg), and Tularemia ("Rabbit Fever" transmitted via ticks).

Tick Removal Protocol
Step 1: Sanitize needle-nose tweezers (not dull or flat) and the bite site; Step 2: Grasp the tick directly on the head as close to the skin as possible; Step 3: Pull slowly and straight upwards to prevent mouthpart breakage.
Measles vs. Rubella
Vaccine-preventable viral exanthems: Measles presents with buccal Koplik spots and a non-blanching facial rash that spreads downwards; Rubella (German Measles) presents with enlarged lymphadenopathy and a pink maculopapular rash initiating on the trunk without coalescence.
Mantoux Tuberculin Skin Test (TST)
An intradermal screening test for tuberculosis where a 5ââ15â needle angle injects tuberculin just below the epidermis of the forearm to produce a 6â10mm wheal; read 48â72Â hours later by measuring the millimeter diameter of palpable induration rather than erythema.
Directly Observed Therapy (DOT)
A public health adherence strategy where a healthcare professional directly observes a tuberculosis patient swallow each medication dose to prevent non-compliance and drug resistance.
Acquired Immunodeficiency Syndrome (AIDS) Criteria
The clinical diagnosis of advanced HIV defined by an established HIV infection alongside a CD4 T-lymphocyte cell count dropping below 200cells/mm3 or the diagnosis of an AIDS-defining opportunistic illness.
Nationally Notifiable Diseases
A designated group of approximately 120 infectious diseases (including cholera, botulism, anthrax, gonorrhea, syphilis, rabies, and tuberculosis) that healthcare providers and laboratories are mandated to report by case numbers to the CDC for epidemiological tracking.